ANGLE plc (LON:AGL – Get Free Report)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 13.95 ($0.18) and traded as low as GBX 7.64 ($0.10). ANGLE shares last traded at GBX 8 ($0.10), with a volume of 574,564 shares.
Analyst Upgrades and Downgrades
Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 70 ($0.91) target price on shares of ANGLE in a report on Thursday, September 26th.
Read Our Latest Research Report on ANGLE
ANGLE Stock Up 3.2 %
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Read More
- Five stocks we like better than ANGLE
- How Investors Can Find the Best Cheap Dividend Stocks
- Survey Reveals: America’s Most Coveted Businesses in 2024
- What is Put Option Volume?
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- What is a Dividend King?
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.